28Ȧ¼ÓÄôó-×·Ç󽡿µ,ÄãÎÒÒ»Æð³É³¤

µ±Ç°Î»Öãº28Ȧ¼ÓÄôó>ÆäËûÊÔ¼Á>Delivector? Avertin £¨Ð¡Êó£©

²úÆ·Ãû³Æ£ºDelivector? Avertin £¨Ð¡Êó£©

Ó¢ÎÄÃû³Æ£ºDelivector? Avertin £¨Ð¡Êó£©

²úÆ·»õºÅ£ºDW3101

²úÆ·°ü×°£º10ml*10

²úÆ·¼Û¸ñ£º450

±£´æÎ¶ȣº4¡æ±Ü¹â

±£ÖÊÆÚ£º1Äê

˵Ã÷ÊéÏÂÔØ

²úÆ·¼ò½é:

· ±¾Æ·°¢·ð¶¡£¨Avertin£©ÊǼ´ÓÃÐ͵ÄÎÞ¾úÂé×í¼Á£¬ÆäÓÐЧ³É·ÖΪÈýäåÒÒ´¼£¨Tribromoethanol£¬TBE£©£¬Í¬Ê±Ò²½Ð°¢¸¥¶¡£¬ÊǷǹÜÖÆÒ©Îï£¬Ôø±»ÍƼö×÷Ϊת»ùÒòÊó´«´úÓйصÄÍâ¿ÆÊÖÊõµÄÂé×í¼Á¡£Ê¹ÓÃʱ¸¹Ç»×¢É䣬¼òµ¥·½±ã£¬Âé×íÆðЧʱ¼ä£¼5min£¬Î¬³Öʱ¼äÔÚ24~90min·¶Î§ÄÚ£¬½öÓÃÓÚÄö³ÝÀදÎСÊó£©Âé×í¡£

²úƷĿ¼£º

²úÆ·»õºÅ

²úÆ·Ãû³Æ

²úÆ·¹æ¸ñ

   DW3106

Delivector™ Avertin £¨Ð¡Êó£©

10ml

    DW3100

Delivector™ Avertin £¨Ð¡Êó£©

10ml*5

     DW3101

Delivector™ Avertin £¨Ð¡Êó£©

    10ml*10

     DW3120

Delivector™ Avertin £¨´óÊó£©

    10ml*10

    DW3116

Delivector™ Avertin £¨ÍÃ×Ó£©

     10ml*10

²úÆ·ÓÅÊÆ:

· ÓÅÓÚË®ºÏÂÈÈ©

· Âé×íÆðЧʱ¼ä¶Ì£º£¼5min

· Âé×íά³Öʱ¼ä³¤£º24~90min

· Delivector™ AvertinÄÜͨ¹ýÂ×ÀíÈÏÖ¤£¬·¢SCIÈÏ¿ÉÂé×í¼Á¡£

Âé×íʱ¼äÑéÖ¤±í£º

¹«Ë¾ÑéÖ¤½á¹û

Ʒϵ

ÖÜÁä

×¢Éä¼ÁÁ¿

¸øÒ©·½Ê½

ÆðЧʱ¼ä

Âé×íʱ¼ä

C57BL/6

6-8ÖÜÁä

20 ul/g

ÓÒ¸¹Ç»×¢Éä

СÓÚ2min

30-90min

BALB/c

6-8ÖÜÁä

20 ul/g

ÓÒ¸¹Ç»×¢Éä

СÓÚ2min

30-90min

ÒÔÉÏΪÎÒÃÇÑé֤ʱʹÓó£ÓüÁÁ¿£¬Ð¡/´óÊóÖÜÁ䲻ͬ»ò¸öÌå²îÒ죬ʹÓÃÁ¿Ðè¸ù¾Ýʵ¼ÊÇé¿ö×ÔÐе÷Õû£¬Èç¹ûÐèÒªÑÓ³¤Âé×íʱ¼ä£¬¿É°´³õʼ¼ÁÁ¿1/3²¹´ò£¬ÇëʵÑéÕ߸ù¾ÝÐèÇó½øÐÐԤʵÑé¡£

 

²úÆ·Ó¦ÓÃ:   ½öÓÃÓÚÄö³ÝÀදÎСÊó£©Âé×í¡£

 

±£´æ·½·¨£º³£ÎÂÔËÊ䣬4¶È±Ü¹â±£´æ¡£

· 

×¢ÒâÊÂÏî:

· ¿ª·âºóÍÆ¼öÔÚ2ÖÜÄÚʹÓᣳ¤Ê±¼ä´æ´¢³É·Ö»áÎö³ö»ò·Ö½â£¬Ôì³ÉÂé×íЧ¹ûϽµ£¬ÉõÖÁ¸¹Ä¤Ñס£Ê¹ÓÃǰÇëÎñ±ØÈ·¶¨±êÇ©Éϱ£ÖÊÆÚ£¬²¢¹Û²ìÊÇ·ñ±äÉ«»òÓнᾧÎö³ö¡£Èç¹ûÓо§ÌåÎö³ö£¬¿ÉÒÔ37¶ÈˮԡÈܽâ¡£ÕýʽʵÑéǰÇëÏȽøÐÐԤʵÑé¡£

· ÍƼöÂé×í¼ÁÁ¿£ºÐ¡Êó°´20μl/g¼ÆË㣨´ËÎªÍÆ¼öʹÓÃÁ¿¿É¸ù¾Ýʵ¼ÊÇé¿ö½øÐе÷Õû£©¡£

· ½öÓÃÓÚ¿ÆÑУ¨·ÇÁÙ´²¿ÆÑÐÑо¿£©¡£

 

±¾²úÆ·ÔÚÎÄÕÂÖеÄд·¨£º

Ó¢ÎÄ£º Dowobio £¨Shanghai £¬China£©

ÖÐÎÄ£º ÉϺ£28Ȧ¼ÓÄôó¼¼ÓÐÏÞ¹«Ë¾  Dowobio£¬ÉϺ£

 

ÎÄÏ×£º

1¡¢The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma

2¡¢HIF1α/SLC7A11 signaling attenuates 6-hydroxydopamine-induced ferroptosis in animal and cell models of Parkinson’s disease  

3¡¢Network pharmacology analysis and animal experiment validation of inflammation inhibition by Swertiamarin in treating Ulcerative colitis 

·µ»Ø¶¥²¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿